LPCAT4 activates the WNT-β-catenin pathway in cancer cells, leading to increased cholesterol synthesis, which suggests that LPCAT4 may be a therapeutic target for the treatment of hepatocellular carcinoma. The gene discussed is LPCAT4; the disease is cancer.